Merck KGaA - PDFSEARCH.IO - Document Search Engine

Merck KGaA
Results: 77

#	Item
21	INDEPENDENT REVIEW PROCESS INTERNATIONAL CENTRE FOR DISPUTE RESOLUTION MERCK KGaA, ) Add to Reading List Source URL: www.icann.org Language: English - Date: 2015-01-15 23:07:53 ICANN Merck & Co. Top-level domain Merck KGaA Proposed top-level domain Domain name Internationalized domain name .org Domain name system Internet Generic top-level domain
22	THE INTERNATIONAL CENTRE FOR EXPERTISE OF THE INTERNATIONAL CHAMBER OF COMMERCE CASE No. EXP/419/ICANN/36 (c. EXP/425/ICANN/42) MERCK KGAA Add to Reading List Source URL: newgtlds.icann.org Language: English - Date: 2013-12-06 14:36:33 ICANN Internet governance Internet in the United States United States Department of Commerce Merck KGaA Conscientious objector Merck & Co. .com Internet Domain name system Generic top-level domains
23	ARBITRATION AND MEDIATION CENTER EXPERT DETERMINATION LEGAL RIGHTS OBJECTION Merck KGaA v. Merck Registry Holdings, Inc. Add to Reading List Source URL: newgtlds.icann.org Language: English - Date: 2014-02-27 17:20:16 Internet Identification Law Trademark law Brand management Trademark Uniform Domain-Name Dispute-Resolution Policy Domain name ICANN Domain name system Intellectual property law Internet governance
24	ARBITRATION AND MEDIATION CENTER EXPERT DETERMINATION LEGAL RIGHTS OBJECTION Merck KGaA v. MSD Registry Holdings, Inc. Add to Reading List Source URL: newgtlds.icann.org Language: English - Date: 2014-02-27 17:20:16 Internet Identification Law Trademark law Arbitration Uniform Domain-Name Dispute-Resolution Policy Trademark Domain name ICANN Domain name system Internet governance Intellectual property law
25	ARBITRATION AND MEDIATION CENTER EXPERT DETERMINATION LEGAL RIGHTS OBJECTION Merck & Co, Inc. v. Merck KGaA Add to Reading List Source URL: newgtlds.icann.org Language: English - Date: 2013-09-25 17:53:12 Internet governance Generic top-level domains Brand management Trademark Domain name Uniform Domain-Name Dispute-Resolution Policy .org Merck KGaA Merck & Co. Domain name system Internet Intellectual property law
26	THE INTERNATIONAL CENTRE FOR EXPERTISE OF THE INTERNATIONAL CHAMBER OF COMMERCE CASE No. EXP/419/ICANN/36 (c. EXP/425/ICANN/42) MERCK KGAA Add to Reading List Source URL: newgtlds.icann.org Language: English - Date: 2013-12-06 14:36:33 ICANN Internet governance Internet in the United States United States Department of Commerce Merck KGaA Conscientious objector Merck & Co. .com Internet Domain name system Generic top-level domains
27	ARBITRATION AND MEDIATION CENTER EXPERT DETERMINATION LEGAL RIGHTS OBJECTION Merck KGaA v. Merck Registry Holdings, Inc. Add to Reading List Source URL: newgtlds.icann.org Language: English - Date: 2014-02-27 17:20:16 Internet Identification Law Trademark law Brand management Trademark Uniform Domain-Name Dispute-Resolution Policy Domain name ICANN Domain name system Intellectual property law Internet governance
28	THE INTERNATIONAL CENTRE FOR EXPERTISE OF THE INTERNATIONAL CHAMBER OF COMMERCE CASE No. EXP/428/ICANN/45 MERCK KGAA Add to Reading List Source URL: newgtlds.icann.org Language: English - Date: 2013-12-06 14:36:33 Merck Merck KGaA Conscientious objector ICANN Merck & Co. .com Internet Domain name system Generic top-level domains
29	Kenneth C. Frazier Chairman of the Board and Chief Executive Officer Merck & Co., Inc. Kenneth C. Frazier is chairman of the board and chief executive officer of Merck & Co., Inc. Previously, Ken served as president of M Add to Reading List Source URL: www.merck.com Language: English - Date: 2013-11-25 10:21:38 Dow Jones Industrial Average Merck & Co. Readington New Jersey Pharmaceutical Research and Manufacturers of America Kenneth Frazier Merck KGaA Merck Pharmaceutical industry Schering-Plough
30	ELECTRONICALLY REPRINTED FROM APRIL 2014 WHERE BUSINESS MEETS POLICY VOLUME 34, NUMBER 4 Add to Reading List Source URL: insigniam.com Language: English - Date: 2014-06-27 21:21:51 Pharmaceutical industry Pharmacology Serono Health care in the United States Health Merck Pharmaceutical sciences Merck KGaA

UPDATE